Patient Guide: Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 19 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05744375
Status: TERMINATED
Condition: Locally Advanced Breast Cancer, Metastatic Breast Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 19 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Cádiz, Andalucía
  • Jaén, Andalucía
  • Santander, Cantabria
  • • And 16 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily